Search for content, post, videos

Asgard Therapeutics granted US patent

Asgard Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted Asgard’s foundational patent related to the method of reprogramming cells towards the dendritic cell fate. The patent provides protection and market exclusivity of products based in the cell
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.